Symbol
CTSO on Nasdaq
Investment type
Equity / Common Stock
Latest Disclosed Shares Owned
5,230,099 shares
Security Ownership %
8.3%
Shares, Excluding Options vs Price
Value, Excluding Options

AVENIR CORP ownership in Cytosorbents Corp Common Stock (CTSO)

13 Feb 2026 - AVENIR CORP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5,230,099 shares of Cytosorbents Corp Common Stock (CTSO). This represents 8.3% ownership of the company. In their previous filing dated 14 Feb 2025, AVENIR CORP had reported owning 3,093,946 shares, indicating an increase of +69%. .
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.